Literature DB >> 11078179

What is critical renal artery stenosis? Implications for treatment.

G Simon1.   

Abstract

Renovascular disease due to progressive atherosclerotic renal artery stenosis is being diagnosed with increasing frequency in the elderly. At what degree of renal artery stenosis should intervention be recommended is not clear. To answer this question, unilateral or bilateral activation of the renin-angiotensin system or its absence were detected by captopril-stimulated renal vein renin measurements in 49 hypertensive patients, aged 63 years, with normal or near-normal renal function (serum creatinine concentration < or =2.0 mg/dL), and the information was matched against radiographic measurements of the extent of renal artery stenosis. With few exceptions, unilateral or bilateral hypersecretion of renin was associated with 80% or greater reduction of renal artery lumen diameter. In contrast, normal secretion or suppression of renin production in a kidney contralateral to an ischemic one was associated with either normal caliber renal artery or renal artery stenosis less than 80%. These findings suggest that renal artery stenosis less than 80% should be monitored rather than treated because improvement of renal function and amelioration of hypertension are not expected unless the renin-angiotensin system has been activated in the affected kidney. Renoprotection by early intervention is uncertain because progression of renal artery stenosis is unpredictable. Normal captopril-stimulated renal vein renin measurements in hypertensive patients obviate the need for further work-up or interventional therapy of renovascular disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078179     DOI: 10.1016/s0895-7061(00)01179-1

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  9 in total

1.  Cardiovascular disease: Stenting in renovascular disease--good news for the heart?

Authors:  Lars Christian Rump; Lorenz Sellin
Journal:  Nat Rev Nephrol       Date:  2012-05-29       Impact factor: 28.314

Review 2.  Timing and selection for renal revascularization in an era of negative trials: what to do?

Authors:  Stephen C Textor; Michael M McKusick; Sanjay Misra; James Glockner
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

Review 3.  Atherosclerotic-nephropathy: an updated narrative review.

Authors:  Mariadelina Simeoni; Silvio Borrelli; Carlo Garofalo; Giorgio Fuiano; Ciro Esposito; Alessandro Comi; Michele Provenzano
Journal:  J Nephrol       Date:  2020-04-08       Impact factor: 3.902

Review 4.  Renovascular hypertension and ischemic nephropathy.

Authors:  Stephen C Textor; Lilach Lerman
Journal:  Am J Hypertens       Date:  2010-09-23       Impact factor: 2.689

5.  [Medicinal or instrumental (corrected) therapy of renal artery stenosis?].

Authors:  L C Rump; L Sellin
Journal:  Internist (Berl)       Date:  2012-06       Impact factor: 0.743

Review 6.  Clinical practice. Renal-artery stenosis.

Authors:  Lance D Dworkin; Christopher J Cooper
Journal:  N Engl J Med       Date:  2009-11-12       Impact factor: 91.245

7.  The cardiovascular outcomes in renal atherosclerotic lesions study and the future of renal artery stenting.

Authors:  Samuel J Mann; Thomas A Sos
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-20       Impact factor: 3.738

8.  Renal artery stenosis presenting as preeclampsia.

Authors:  Michael Brandon Omar; William Kogler; Satish Maharaj; Win Aung
Journal:  Clin Hypertens       Date:  2020-04-01

9.  Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.

Authors:  Asife Sahinarslan; Emine Gazi; Meryem Aktoz; Cigdem Ozkan; Gülay Ulusal Okyay; Ozgul Ucar Elalmis; Erdal Belen; Reviewers Atila Bitigen; Ulver Derici; Neslihan Bascil Tutuncu; Aylin Yildirir
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.